HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The genetically-engineered secretory B27/Q10 chimeric molecule inhibits HLA-B27 restricted alloreactive T-lymphocytes.

AbstractOBJECTIVES:
Intracellularly persisting bacterial infections and high association with HLA-B27 are the hallmarks of reactive arthritis. Soluble HLA-B27 molecules are induced by bacterial infection; however their biological role in arthritis is unknown. It was the aim of this study to generate soluble HLA-B27 molecule and to analyze its effect on cytotoxic HLA-B27 alloreactive CD8+ T-lymphocytes in order to better understand potential functional links between persistent infection and HLA-B27 association.
METHODS:
Using PCR Exons 1 through 4 of HLA-B*2705 were fused to Exon 5 of the soluble murine MHC class I variant Q10 and stably transfected into Hela-cells. Transfectants were analyzed using specific PCR, RT-PCR and intracellular and extracellular staining with anti-HLA-B27 monoclonal antibody ME1. Secretion of B27Q10 in the supernatant was examined by isoelectric focusing (IEF). The effect of B27Q10 on T-cells was analyzed using either HLA-B27- or HLA-A2-restricted alloreactive T-cells in a standard 51Cr-release assay.
RESULTS:
PCR and RT-PCR demonstrated the DNA and mRNA of B27Q10 in the transfectants. By intracellular and extracellular staining with ME1 B27Q10-molecule was detected intracellularly but was not expressed in the cell membrane. Using IEF soluble B27Q10-molecules were found in supernatants of transfectants in a concentration of up to 1.342 microg/ml. Soluble B27QJO-molecule inhibited specifically the cytotoxicity of HLA-B27-restricted alloreactive T-cells by about 30%.
CONCLUSION:
The secretory non-membrane-expressed molecule B27Q10 inhibits HLA-B27 specific T-cells. The inhibition of cytotoxic T-cells by bacteria induced soluble HLA-B27 may thus enable bacterial persistence.
AuthorsJ G Kuipers, A Bialowons, P Dollmann, M C Jendro, N Wagener, V Rebmann, M Ikeda, F Huang, H Grosse-Wilde, D T Y Yu, H Zeidler, E Märker-Hermann
JournalClinical and experimental rheumatology (Clin Exp Rheumatol) 2002 Jul-Aug Vol. 20 Issue 4 Pg. 455-62 ISSN: 0392-856X [Print] Italy
PMID12175099 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • HLA-B27 Antigen
  • Histocompatibility Antigens Class I
  • Q surface antigens
  • RNA, Messenger
  • Recombinant Fusion Proteins
  • DNA
Topics
  • Animals
  • CD8-Positive T-Lymphocytes (drug effects, immunology)
  • Cloning, Molecular
  • DNA (analysis)
  • DNA Primers (chemistry)
  • Dose-Response Relationship, Drug
  • Gene Library
  • Genetic Engineering
  • HLA-B27 Antigen (genetics, metabolism)
  • HeLa Cells
  • Histocompatibility Antigens Class I (genetics, metabolism)
  • Humans
  • Mice
  • RNA, Messenger (biosynthesis, metabolism)
  • Recombinant Fusion Proteins (pharmacology)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: